Information Provided By:
Fly News Breaks for January 10, 2020
Jan 10, 2020 | 08:35 EDT
Raymond James analyst Elliot Wilbur initiated coverage of Zoetis with a Market Perform rating. In a research note to investors, Wilbur says he believes that the company's current valuation premium to industry peers more than appropriately reflects the stability and consistency of future growth prospects. Apart from broad characteristics that define the animal health industry, such as a faster and less expensive drug development process, preference towards branded vs. generic products due to prescribing patterns, and less concentrated product portfolios, the analyst says he believes Zoetis' premium valuation vs. peers will likely persist.
News For ZTS From the Last 2 Days
There are no results for your query ZTS